Transrectal high‐intensity focused ultrasound for the treatment of localized prostate cancer: Eight‐year experience
Authors:
- 21 October 2009
- journal article
- Published by Wiley in International Journal of Urology
- Vol. 16 (11) , 881-886
Abstract
Objective: To report on the long‐term results of high‐intensity focused ultrasound in the treatment of localized prostate cancer.Methods: A total of 517 men with stage T1c–T3N0M0 prostate cancer treated with Sonablate devices (Focus Surgery, Indianapolis, IN, USA) between January 1999 and December 2007 were included in the study. Biochemical failure was defined according to the Phoenix definition (prostate‐specific antigen nadir + 2 ng/mL).Results: The median follow‐up period for all patients was 24.0 months (range, 2 to 88). The biochemical disease‐free rate (BDFR) in all patients at 5 years was 72%. The BDFR in patients with stage T1c, T2a, T2b, T2c and T3 groups at 5 years were 74%, 79%, 72%, 24% and 33%, respectively (P < 0.0001). BDFR in patients in the low, intermediate and high‐risk groups at 5 years were 84%, 64% and 45%, respectively (P < 0.0001). The BDFR in patients treated with or without neoadjuvant hormonal therapy at 7 years were 73% and 53% (P < 0.0001), respectively. In multivariate analysis, pretreatment prostate‐specific antigen levels (hazard ratio 1.060; P < 0.0001; 95% confidence interval 1.040–1.080), neoadjuvant hormonal therapy (hazard ratio 2.252; P < 0.0001; 95% confidence interval 1.530–3.315) and stage (P = 0.0189) were demonstrated to be statistically significant variables. Postoperative erectile dysfunction was noted in 33 out of 114 (28.9%) patients who were preoperatively potent.Conclusions: High‐intensity focused ultrasound therapy appears to be minimally invasive, efficacious and safe for patients with localized prostate cancer, particularly those with low‐ and intermediate‐risk cancer.Keywords
This publication has 19 references indexed in Scilit:
- Efficacy of Short-Term Androgen Deprivation With High-Intensity Focused Ultrasound in the Treatment of Prostate Cancer in JapanUrology, 2008
- Will focal therapy become a standard of care for men with localized prostate cancer?Nature Clinical Practice Oncology, 2007
- Laparoscopic Radical Prostatectomy for Localized Prostate Cancer: A Systematic Review of Comparative StudiesJournal of Urology, 2006
- Five years experience of transrectal high‐intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancerInternational Journal of Urology, 2006
- CANCER PROGRESSION AND SURVIVAL RATES FOLLOWING ANATOMICAL RADICAL RETROPUBIC PROSTATECTOMY IN 3,478 CONSECUTIVE PATIENTS: LONG-TERM RESULTSJournal of Urology, 2004
- High-Intensity Focused Ultrasound and Localized Prostate Cancer: Efficacy Results from the European Multicentric StudyJournal of Endourology, 2003
- High intensity focused ultrasound (HIFU) and neoadjuvant transurethral resectionEuropean Urology Supplements, 2003
- The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunctionInternational Journal Of Impotence Research, 2002
- CANCER CONTROL WITH RADICAL PROSTATECTOMY ALONE IN 1,000 CONSECUTIVE PATIENTSJournal of Urology, 2002
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999